Scienture HoldingsSCNX -3.56%47 Gross Margin % is 96.43% as of Mar. 2026, which is 79% above its 10-year median of 53.84. GuruFocus rates SCNX with a GF Score™ of 47/100 and a GF Value™ of $0.35 (Fairly Valued). The stock has 6 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Scienture Holdings ranks better than 87.8% on this metric.
Scienture Holdings Inc gross margin has been in long-term decline. The average rate of decline per year is -15.1%.
The historical rank and industry rank for Scienture Holdings's Gross Margin % or its related term are showing as below:
SCNX'
s Gross Margin % Range Over the Past 10 Years
Min: 3.59 Med: 53.84 Max: 99.36
Current: 80.71
During the past 13 years, the highestGross Margin % of Scienture Holdings was 99.36%. The lowest was 3.59%. And the median was 53.84%.
SCNX's Gross Margin % is ranked better than 87.8% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs SCNX: 80.71
Scienture Holdings had a gross margin of 96.43% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Scienture Holdings was -15.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Scienture Holdings had a gross margin of 96.43% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Scienture Holdings Gross Margin % Related Terms
Scienture Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for Scienture Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCNX vs WGRX, HEWA, BLMH: Gross Margin % Comparison
For the Pharmaceutical Retailers subindustry, Scienture Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scienture Holdings Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scienture Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Scienture Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Scienture Holdings (SCNX) has a Gross Margin % of 96.43% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Scienture Holdings and its competitors. This is 79% above median its historical median of 53.84. Over the past decade, Scienture Holdings' Gross Margin % has ranged from 3.59 to 99.36. According to the industry distribution chart, Scienture Holdings ranks #77 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Scienture Holdings' Gross Margin % too high?
Scienture Holdings' current Gross Margin % of 96.43% is 79% above median its 10-year median of 53.84. Over the past 10 years, this metric has ranged from a low of 3.59 to a high of 99.36. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Scienture Holdings' value of 96.43% is 140.5% above this industry median. Based on the distribution chart, Scienture Holdings ranks #77 out of 631 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Scienture Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scienture Holdings' Gross Margin % compare to WGRX and HEWA?
According to the Healthcare Providers & Services industry distribution chart, Scienture Holdings ranks #77 out of 631 companies for Gross Margin %. This places Scienture Holdings in the top 12% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.09. Scienture Holdings' value of 96.43% is 140.5% above this benchmark. Historically, Scienture Holdings' own Gross Margin % has ranged from 3.59 to 99.36 over the past decade. While the company's 10-year median is 53.84 vs. the industry median of 40.09, Scienture Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scienture Holdings's current Gross Margin % of 96.43% is 140.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Scienture Holdings and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scienture Holdings's current Gross Margin % is 96.43%, which is 79% above median its own 10-year median of 53.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scienture Holdings stock overvalued right now?
Based on GuruFocus' analysis, Scienture Holdings (SCNX) is currently considered Fairly Valued. The stock's GF Value™ is $0.35, compared to a current price of $0.37 — trading 6.3% above its estimated fair value. The current Gross Margin % is 96.43%, which is 79% above median its 10-year median of 53.84 and 140.5% above the Healthcare Providers & Services industry median of 40.09. Scienture Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Scienture Holdings (SCNX), the current Gross Margin % is 96.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scienture Holdings (SCNX) Overvalued in 2026?
Based on GuruFocus' analysis, Scienture Holdings stock appears to be overvalued.
The current stock price of $0.37 is trading 6.3% above its estimated GF Value™ of $0.35.
GuruFocus considers Scienture Holdings to be Fairly Valued.
Key valuation signals for SCNX:
Gross Margin %: 96.43% (79% above median its 10-year median of 53.84)
GF Value™: $0.35 vs. price of $0.37 (6.3% above fair value)
Industry Position: 140.5% above the Healthcare Providers & Services median (#77 of 631)
No single metric tells the full story. See the SCNX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
47GF Score
Get the complete analysis for SCNX
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCNX has been successfully added to your 
